Table 1.
Characteristics of the study population (n = 98).
| Characteristics | Value |
|---|---|
| Demographics | |
| Age (years) | 49 ± 11 |
| Gender, male (%) | 53 (54.1%) |
| Ethnicity, white | 84 (85.7%) |
| BMI (Kg/m2) | 25.45 (23.6–28.2) |
| Physical activity* | 18 (18.4%) |
| Comorbidities | |
| Hypertension (%) | 27 (27.6%) |
| IFG/Diabetes (%) | 35 (35.7%) |
| Metabolic syndrome (%) | 31 (31.6%) |
| Dyslipidemia | 79 (80.6%) |
| Laboratory | |
| Triglycerides (mg/dl) | 156 (118–2–8) |
| Total cholesterol (mg/dl) | 188.6 ± 34 |
| Low density lipoprotein cholesterol (mg/dl) | 103.3 ± 30 |
| High density lipoprotein cholesterol (mg/dl) | 45.50 (38–55) |
| Aspartate aminotransferase (U/L) | 21 (17–26) |
| Alanine aminotransferase (U/L) | 22 (16–30) |
| Total bilirubin | 0.4 (0.3–1.2) |
| HIV | |
| Time since HIV (years) | 15 (6–20) |
| Time on ART (years) | 11 (5–16) |
| CD4 count (cells/µL) | 657.5 (118–208) |
Data were expressed as number (%), mean ± standard deviation (SD) for quantitative variables with normal distribution, or median (IQR) for quantitative variables without normal distribution.
Abbreviations: BMI, body mass index; IGF, impaired fasting glucose; ART, antiretroviral therapy.
*Physical activity was considered above 3 times a week.